PRESS RELEASE
News
-
-
PRESS RELEASE
New to The Street Announces 12-Month National Media Partnership with Stardust Power (NASDAQ: SDST)
Stardust Power partners with New to The Street for 12-month national media collaboration. The partnership includes TV interviews, media placements, TV commercials, and billboard campaigns to showcase America's energy leadership efforts -
PRESS RELEASE
Bird River Announces Closing of 4th Tranche of Common Share Financing For Gross Proceeds of Approximately $709,299 and Early Warning Disclosure
Bird River Resources Inc. closed a fourth tranche of private placement financing, issuing 8,866,239 Common Shares at $0.08 per share, with aggregate gross proceeds of $709,299.12 for general corporate purposes -
-
PRESS RELEASE
Eightco Holdings Inc. ($ORBS) Digital Asset Treasury Launches "Chairman's Message" Video Series
Eightco Holdings Inc. launches 'Chairman's Message' video series to support the 'Power of Eight' initiative, focusing on Worldcoin (WLD) tokens and Proof-of-Human verification for the AI era. The company aims to acquire 800M WLD tokens with a $10 projection, potentially valuing at $8B -
PRESS RELEASE
Déclaration du nombre total de droits de vote et du nombre d’actions composant le capital au 30 septembre 2025
L'Oréal annonce les chiffres du capital et des droits de vote au 30 septembre 2025. Le groupe est leader mondial de la beauté depuis 115 ans, avec un chiffre d'affaires de 43,48 milliards d'euros en 2024. L'Oréal est nommé entreprise la plus innovante d'Europe en 2025 par le magazine Fortune -
PRESS RELEASE
Disclosure of total number of voting rights and number of shares in the capital at September 30, 2025
L'Oréal, a French limited company with a registered capital of 106,640,982.60 euros, discloses its voting rights and shares. The leading beauty player emphasizes sustainability and innovation -
-
PRESS RELEASE
2025 International MICE Summit (IMS) to convene global leaders as Vision 2030 powers Saudi Arabia's rise as a global hub for business events
Saudi Arabia to host International MICE Summit (IMS25) bringing over 2,000 global leaders, reinforcing its position as a major business events destination under Vision 2030 -
PRESS RELEASE
Protagonist Announces New Icotrokinra Data in Ulcerative Colitis Showing Potential for a Standout Combination of Therapeutic Benefit and a Favorable Safety Profile in Once-daily Pill
Icotrokinra meets primary clinical endpoints in Phase 2b study for ulcerative colitis treatment, showing promising results at Week 12. Phase 3 trials expected to start in Q4 2025
